Evidence map›Paper›PMID 38224397›Full record

ArticleJournal of cancer survivorship : research and practice2025

Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention in adolescent and young adult (AYA) cancer survivors: results from the SURVAYA study.

Costanza Gavioli, Carla Vlooswijk, Silvie H M Janssen, Suzanne E J Kaal, J Martijn Kerst, Jacqueline M Tromp, Monique E M M Bos, Tom van der Hulle, Winette T A van der Graaf, Roy I Lalisang and 5 more

Abstract read
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Costanza GavioliDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, 3511 DT, Utrecht, The Netherlands.
Carla VlooswijkDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, 3511 DT, Utrecht, The Netherlands.
Silvie H M JanssenDepartment of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
Suzanne E J KaalDepartment of Medical Oncology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands.
J Martijn KerstDepartment of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.
Jacqueline M TrompDepartment of Medical Oncology, Amsterdam University Medical Center, 1105 AZ, Amsterdam, The Netherlands.
Monique E M M BosDepartment of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD, Rotterdam, The Netherlands.
Tom van der HulleDepartment of Medical Oncology, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands.
Winette T A van der GraafDepartment of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.
Roy I LalisangDepartment of Internal Medicine, GROW-School of Oncology and Reproduction, Maastricht UMC+ Comprehensive Cancer Center, 6229 HX, Maastricht, The Netherlands.
Janine NuverDepartment of Medical Oncology, University Medical Center Groningen, 9713 GZ, Groningen, The Netherlands.
Rhodé M BijlsmaDepartment of Medical Oncology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands.
Mathilde C M KouwenhovenDepartment of Neurology, Amsterdam UMC, Amsterdam University Medical Centers, Location VUmc, 1081 HV, Amsterdam, The Netherlands.
Olga HussonDepartment of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. o.husson@erasmusmc.nl.
Sandra BeijerDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, 3511 DT, Utrecht, The Netherlands.

Funding

KWF Kankerbestrijding #11788Nederlandse Organisatie voor Wetenschappelijk Onderzoek 198.007
6 · The paper itself

Abstract

purposeFor adolescent and young adult (AYA) cancer survivors with a good prognosis, having a healthy lifestyle prevents morbidity and mortality after treatment. The aim of this study was to investigate the prevalence of (un)healthy lifestyle behaviors and related determinants in AYA cancer survivors.

methodsA population-based, cross-sectional study was performed among long-term (5-20 years) AYA cancer survivors (18-39 years old at diagnosis) registered within the Netherlands Cancer Registry. Self-reported questionnaires data about health behaviors were used to calculate the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) adherence score. Associations between the score and clinical/sociodemographic determinants of (un)healthy behaviors were investigated using logistic regression models.

resultsThe mean WCRF/AICR score was low to moderate, 3.8 ± 1.2 (0.5-7.0) (n = 3668). Sixty-one percent adhered to "limit the consumption of sugar sweetened drinks," 28% to "be a healthy weight," 25% to "fruit and vegetable consumption," and 31% to "limit alcohol consumption." Moderate and high adherence were associated with being a woman (OR

conclusionsAdherence to the 2018 WCRF/AICR lifestyle recommendations was low to moderate, especially regarding body weight, fruit, vegetables, and alcohol consumption. Men, current smokers, lower-educated participants, and/or those diagnosed with germ cell tumors were less likely to have a healthy lifestyle. IMPLICATIONS FOR CANCER SURVIVORS: Health-promotion programs (e.g., age-specific tools) are needed, focusing on high-risk groups.

Indexed as

Cancer SurvivorsHealth BehaviorHealthy LifestyleNeoplasmsAdolescentAdultCross-Sectional StudiesFemaleHumansMaleNetherlandsYoung AdultAdolescents and young adults with cancer (AYAs)DeterminantsHealth behaviorSurvivorsWCRF/AICR recommendations

Identifiers

PMID38224397
PMCPMC12081526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.